Kate Therapeutics
Shayan Tabe Bordbar is a Bioinformatics Scientist II at Kate Therapeutics. Prior to this role, Shayan was a PhD Candidate at the University of Illinois at Urbana-Champaign. Shayan holds a Doctor of Philosophy in Computer Science from the University of Illinois Urbana-Champaign, as well as Master's degrees in Bioinformatics and Molecular and Integrative Physiology from the same institution. Additionally, Shayan has a Master's degree in Biotechnology from the University of Tehran and a Bachelor's degree in Biotechnology from the same university.
Kate Therapeutics
Kate Therapeutics (KateTx) is a patient-focused biotechnology company developing adeno-associated virus (AAV)-based gene therapies to treat genetically defined muscle and heart diseases. The company is applying novel technology platforms that directly address the key limitations of current gene therapies, including tissue-specific delivery and gene regulation. These breakthroughs have the potential to improve the efficacy and safety of gene therapies and enable the pursuit of a broader set of targets that are otherwise difficult to drug with current technologies.